Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

2020622 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 8, Issue 10, pp. 963-974

Field-Weighted Citation Impact: 51.87